Paid Sick Leave Means More People Get Screened for Cancer
Sick leave coverage expansion were associated with higher rates of mammography screening and colorectal screening, potentially leading to better health outcomes.
University of California San Francisco
Give to UCSF
Displaying 781 - 810 of 16406
-
-
S.F. Composers Meld Sound With Science for New Perspective on Alzheimer’s
-
Doxycycline for STI Prevention: Highly Effective, Minimal Drug Resistance
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
-
UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UCSF’s Heart and Vascular Center participation in a new Cardiogenic Shock Registry aims to improve treatment for cardiogenic shock types.
-
When Can I Get a Second Bivalent COVID Booster? Here’s What We Know Right Now
-
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May Have Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue
-
How to Improve COVID Vaccination Rates With Emergency Room Messaging
UCSF researchers found that distributing pro-COVID-19 vaccine information in EDs in English and Spanish increased vaccine acceptance, especially among Latinos and those without primary care physicians.
-
UCSF is No. 1 Public Recipient of National Institutes of Health Funding in 2022
UCSF is a leading recipient of National Institutes of Health (NIH) funding for research, with a focus on advancing health sciences and medicine.
-
Artist, Who Has Spent a Decade Working With Patients at UCSF Children’s Hospital, Receives Kindness Award
-
What Is Disordered Eating? And Why Do 20% Of the World’s Kids Show Signs of It? Experts Explain
-
There Is an Increase in Syphilis in the US, What You Need To Know
-
Science World Honors Kevan Shokat for High-Impact Cancer Research
Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.
-
How a Consistent Sleep Schedule Might Protect Your Heart
-
‘This Is a First’: Why a 5-Hour Heart Transplant at UCSF Made History
-
Plant-based Foods May Reduce Prostate Cancer Progression, Study Says
-
An Allergy Drug Showed Promise for MS. Could They Prove It?
Proof of an over-the-counter allergy drug’s ability to reverse progression of multiple sclerosis provides monumental change for MS patients.
-
How UCSF Grad Students Mentor Diverse High Schoolers in STEM
BAYS internship initiative welcomes students from historically excluded backgrounds into UCSF labs to counter disparities among Black and Latino students who pursue STEM careers.
-
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
-
Winter Is Tough on Skin. Experts Offer Tips To Ease Itchiness.
-
In-Hospital Treatment Can Help Address Youth Opioid Addiction: Report
-
UCSF’s CURE Internship Program Jumps Back to True Self
-
Even a Brain-Eating Amoeba Can’t Hide From This Cutting-Edge Diagnosis Tech
-
Here’s Why You Should Start Taking Seasonal Allergy Meds Sooner Than You Think
-
$500 Seed Money Boosts Parents’ College Goals for Kids
Oakland Promise’s Brilliant Baby program seeds $500 college funds for Medi-Cal-eligible babies, provides families with free financial coaching, and offers educational programming for caregivers.
-
What We Were Taught About RNA in High School is Only Half the Picture
Vissers’ work on RNA tags helped found the field of epitranscriptomics, the study of how chemical marks on RNA, rather than their sequence alone, dictate the function of the molecules.
-
The Omicron Effect: Can We Predict the Next Viral Killer?
Angela Phillips, PhD, leads research that could help predict future viruses like COVID and the antibodies we might use to treat them.
-
Breaking the Code on Dangerous Lung Inflammation
When we inhale an airborne virus, our lung cells take on the role of immune system first responders. Catera Wilder, PhD, studies the molecular details of this response and how it can go awry, causing the body to damage its own tissue and cells.
-
Why Stem Cell Therapy Might Not Work for Older Patients
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
-
What Enzymes Can Tell Us About Human Health and Global Warming
Because proteins can adapt to extremes, Margaux Pinney, PhD, believes they can show how living organisms might adapt to climate change.
-
Can We Turn Back Time on Age-Related Diseases?
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
